Authors

Rusfertide Maintains Hematocrit Control Through 52 Weeks in VERIFY

Rusfertide shows promising results as a first-in-class therapy for polycythemia vera, demonstrating sustained hematocrit control and safety in recent studies.

ALA Offers New Resources to IPF Patients

At the most recent American Lung Association LUNGFORCE expo, RDR sat down with Carly Ornstein to discuss the new resources made available by the ALA to individuals affected by lung fibrosis.

Angiotensin-converting enzyme inhibitors in elderly patients with acute myocardial infarction: A class effect?

Using a retrospective observational study design, we assessed whether all angiotensin-converting enzyme (ACE) inhibitors had similar mortality rates after acute myocardial infarction in patients aged 65 years or older. Our results showed that mortality rates for enalapril, fosinopril, captopril, and quinapril were higher than that for ramipril. This suggests that there is no class effect for ACE inhibitors. Further research is needed to confirm the results of our study.

Triglycerides and EPA: A New Chapter in CV Disease Prevention

Findings from REDUCE-IT are the first to show that EPA lowers the relative risk of hard cardiovascular endpoints. Johns Hopkins' Seth Martin, MD, and colleagues put the trial in perspective. 

LTC Insurance Sidesteps Nursing Homes

Healthcare 2020: Video, Vaping, Value and More

From new tech, to better therapy, to resolution on vaping, what will dominate discussion in US medicine this decade?

Laboratory monitoring for spironolactone in congestive heart failure

We evaluated how well patients taking spironolactone were monitored for hyperkalemia, as well as the association between spironolactone and hyperkalemia. Only two thirds of patients received testing for serum potassium and creatinine levels, and higher baseline serum creatinine levels predicted a high risk of hyperkalemia. These results indicate that appropriate patient selection and close monitoring are essential, especially for patients with renal impairment.

My Patient Is Stalking Me Online

Although the adage that there is no privacy on the Internet is truer than ever, there are several steps that physicians can take to protect their private lives and information while still remaining active online.

Implementing Price Transparency Tools at Ambulatory Care Centers

Patients are satisfied with an online cost-estimator tool, according to findings of a recent study.

Physicians' Investment Decisions Magnified Due to Earnings Potential Uncertainty

Many physicians are feeling the earnings squeeze amidst the tectonic shifts in the health care system and changing US demographics.